Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors

Riccardo Sarzani1, Marica Bordicchia, Francesco Spannella

  • 1Internal Medicine and Geriatrics, "Hypertension Excellence Centre" of the European Society of Hypertension, Department of Clinical and Molecular Sciences, University "Politecnica delle Marche", Italian National Research Centre on Aging "U. Sestilli", IRCCS-INRCA, via della Montagnola n. 81, 60127, Ancona, Italy, sarzani@univpm.it.

Insights

Obesity nearly doubled worldwide, increasing cardiovascular disease. A vascular-metabolic syndrome hypothesis suggests impaired natriuretic peptide systems link obesity to high blood pressure and hypertensive heart disease (HHD).

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Syndrome
  • Obesity Research

Background:

  • Global obesity rates have doubled, significantly increasing cardiovascular disease and mortality.
  • Overweight and obesity are linked to hypertension and hypertensive heart disease (HHD).
  • Existing research highlights multiple factors contributing to HHD in obese individuals.

Purpose of the Study:

  • To review and synthesize the bridging factors between excessive adiposity and HHD.
  • To propose a unifying hypothesis of vascular-metabolic syndrome.
  • To emphasize the central role of the natriuretic peptide system.

Main Methods:

  • Literature review and synthesis of existing research on obesity, hypertension, and cardiovascular disease.
  • Analysis of factors linking adiposity to hypertensive heart disease.
  • Development of a theoretical framework for vascular-metabolic syndrome.

Main Results:

  • Excessive adiposity contributes to HHD through complex vascular and metabolic pathways.
  • A compromised natriuretic peptide system is implicated in both adipocyte dysmetabolism and elevated blood pressure.
  • The proposed vascular-metabolic syndrome integrates these factors.

Conclusions:

  • The natriuretic peptide system plays a critical role in the development of HHD in the context of obesity.
  • Understanding this vascular-metabolic link can inform new therapeutic strategies.
  • Further research is needed to validate the vascular-metabolic syndrome hypothesis and the role of natriuretic peptides.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
365
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.8K